“I am pleased to see that the changes we’ve implemented within our sales organization are translating into tangible momentum,” said Jeffrey Blizard, president. “Our continued focus on building a patient-centric, performance-driven culture-grounded in fiscal discipline-is delivering results and laying a strong foundation to re-accelerate growth in 2026.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELA:
- TELA Earnings this Week: How Will it Perform?
- TELA Bio Appoints William Plovanic to Board
- Tela Bio’s OviTex PRS Study: A New Frontier in Breast Reconstruction
- Tela Bio’s OviTex Study: A Potential Game-Changer in Hernia Repair
- Tela Bio’s OviTex Study: A Potential Game-Changer for Hiatal Hernia Treatment